Myomo, Cambridge, Massachusetts, has received a $50,000 seed grant from the Philadelphia Pediatric Medical Device Consortium (PPDC) to develop the MyoPro Motion-K. The MyoPro Motion-K, a pediatric-size version of the MyoPro device, assists with motion and function in children with neuromuscular disorders. Myomo was one of three companies chosen from eight finalists in the competition.
The PPDC, a collaboration between the Children’s Hospital of Philadelphia, Drexel University, and the University of Pennsylvania, is funded by the U.S. Food and Drug Administration and helps innovators translate promising ideas into commercial medical devices for use in children.
“We are once again delighted to support promising, innovative medical devices geared to the unmet clinical needs of children,” said engineer Matthew R. Maltese, PhD, of the Children’s Hospital of Philadelphia, the consortium’s executive director and principal investigator.